Cost-Effective and Robust Continuous Biotech Bio-Based Processes

About

The European Commission is offering €14 million in funding for projects that aim to revolutionize biotech processes by transitioning to continuous biotech bio-based processes, contributing to EU initiatives on sustainability, circular economy, and industrial competitiveness.

Benefits

• Funding of €14 million for projects
• Contribution to EU initiatives on Biotech and Biomanufacturing, Circular Economy, Zero Pollution, and Industrial Strategy
• Expected outcomes include increased scale-up potential, productivity, and sustainability of biotech processes.

Eligibility Criteria

• Legal entities from EU Member States, associated countries, and certain international organizations are eligible to participate
• Legal entities must meet conditions laid out in the Horizon Europe Regulation
• Entities eligible for funding must be established in specific countries listed in the call.